#United States #New York #Healthcare Innovation #120/80 Health Group #Svoboda Capital

120/80 Health Group Forms Strategic Alliance with Svoboda Capital Partners

In a significant development within the healthcare consultancy sector, 120/80 Health Group has announced a strategic partnership with Svoboda Capital Partners, a private equity firm that specializes in backing founder-led companies. This partnership is expected to catalyze an exciting new phase in the growth trajectory of 120/80 Health Group, which has established itself as one of the leading communications and strategic consultancies in the health sector since its inception in 2018.

Background of 120/80 Health Group

Founded in New York City, 120/80 Health Group has witnessed continuous growth, consistently evolving its services to meet the needs of digital health startups at various stages of their development. Initially focused on increasing brand visibility for early-stage companies, the firm has expanded to become a comprehensive strategic consultancy that offers measurable outcomes for clients ranging from pre-Series A entities to publicly traded organizations.

The agency's specialization in healthcare and life sciences equips it with unique insights that facilitate the cultivation of significant business relationships. By leveraging its industry knowledge, 120/80 Health Group excels in marketing innovative ideas, accelerating product adoption, establishing category leadership, and driving sustainable growth.

The Partnership's Vision

The partnership with Svoboda Capital Partners aims to reinforce and expand the consultancy's capabilities. This collaboration will empower 120/80 Health Group to reinvest in talent and broaden its service offerings to better serve the evolving needs of its clients. Rob Cronin, the founder and CEO of 120/80 Health Group, expressed enthusiasm regarding the potential of this strategic alliance. He emphasized the mutual vision shared with Svoboda—to harness technology, AI, and innovative healthcare models to enhance accessibility to care, develop novel therapies, and ultimately save lives.

“From our launch, we believed that the future of healthcare hinged on technological advancements,” Cronin remarked. “This partnership not only aligns with our vision but also strengthens our commitment to supporting founders and leaders who are passionate about reshaping the healthcare landscape.”

What Svoboda Capital Brings to the Table

Svoboda Capital Partners is known for its impressive track record in partnering with prominent professional services firms. By aligning with 120/80 Health Group, Svoboda seeks to provide not just financial backing, but also strategic expertise that is vital for navigating the complexities of the healthcare landscape.

Will King, managing director at Svoboda, highlights the firm’s dedication to preserving the unique culture of its partner companies while delivering the support necessary for growth. “Our collaboration with 120/80 Health Group exemplifies our commitment to investing in top-tier strategic communications firms that provide exceptional value to their clients,” King noted.

Future Aspirations

With this new strategic partnership, 120/80 Health Group aims to build a robust platform that can cater to the needs of innovators in the healthcare and life sciences fields. The firm is driven by a simple yet profound mission: ensuring that no healthcare innovation fails to reach those who need it.

“Together, we will scale our capabilities to serve the dynamic demands of healthcare innovators, facilitating their journey from concept to reality,” expressed Cronin. As the landscape of healthcare continues to evolve, 120/80 Health Group’s forward-thinking approach, backed by Svoboda Capital, positions it to lead transformative changes within the industry.

This partnership not only represents a fusion of expertise and resources but also signifies a concerted effort to continue pioneering advancements in healthcare communications that align with the needs of a rapidly changing market. Through this collaboration, 120/80 Health Group is set to reinforce its stature as a catalyst for impactful healthcare innovations.

For more information about 120/80 Health Group, visit www.12080healthgroup.com and for details on Svoboda Capital Partners, check out www.svoco.com.